RATIONALE AND OBJECTIVES: The positive allosteric modulator of the GABA(B) receptor, GS39,783, has recently been found to suppress acquisition and maintenance of alcohol drinking behavior in selectively bred Sardinian alcohol-preferring (sP) rats exposed to the standard, homecage two-bottle "alcohol vs water" choice regimen. The present study was designed to extend the characterization of the "anti-alcohol" effects of GS39,783 to oral self-administration of alcohol under an operant procedure. MATERIALS AND METHODS: Two separate groups of male sP rats were trained to lever-press (on an FR4 schedule) to orally self-administer alcohol (15%, v/v) or sucrose (0.3%, w/v) in daily 30-min sessions. Once lever-pressing behavior reached stable levels, the effect of GS39,783 (0, 25, 50, and 100 mg/kg, i.g.) on responding for alcohol and sucrose was determined. RESULTS: Pretreatment with GS39,783 resulted in a significant, dose-dependent reduction in responding for alcohol; at the dose of 100 mg/kg GS39,783, the number of lever responses for alcohol was reduced by approximately 50% in comparison to vehicle-treated rats. The effect of GS39,783 on alcohol self-administration was specific, as responding for sucrose was completely unaffected by pretreatment with GS39,783. CONCLUSIONS: These data demonstrate the capability of GS39,783 to attenuate the reinforcing properties of alcohol in alcohol-preferring rats. These data constitute a further piece of experimental evidence in support of the hypothesized role for the GABA(B) receptor in the control of alcohol drinking and reinforcement.
RATIONALE AND OBJECTIVES: The positive allosteric modulator of the GABA(B) receptor, GS39,783, has recently been found to suppress acquisition and maintenance of alcohol drinking behavior in selectively bred Sardinian alcohol-preferring (sP) rats exposed to the standard, homecage two-bottle "alcohol vs water" choice regimen. The present study was designed to extend the characterization of the "anti-alcohol" effects of GS39,783 to oral self-administration of alcohol under an operant procedure. MATERIALS AND METHODS: Two separate groups of male sP rats were trained to lever-press (on an FR4 schedule) to orally self-administer alcohol (15%, v/v) or sucrose (0.3%, w/v) in daily 30-min sessions. Once lever-pressing behavior reached stable levels, the effect of GS39,783 (0, 25, 50, and 100 mg/kg, i.g.) on responding for alcohol and sucrose was determined. RESULTS: Pretreatment with GS39,783 resulted in a significant, dose-dependent reduction in responding for alcohol; at the dose of 100 mg/kg GS39,783, the number of lever responses for alcohol was reduced by approximately 50% in comparison to vehicle-treated rats. The effect of GS39,783 on alcohol self-administration was specific, as responding for sucrose was completely unaffected by pretreatment with GS39,783. CONCLUSIONS: These data demonstrate the capability of GS39,783 to attenuate the reinforcing properties of alcohol in alcohol-preferring rats. These data constitute a further piece of experimental evidence in support of the hypothesized role for the GABA(B) receptor in the control of alcohol drinking and reinforcement.
Authors: Jian-Hui Liang; Feng Chen; Elena Krstew; Michael S Cowen; Fiona Y Carroll; Duncan Crawford; Philip M Beart; Andrew J Lawrence Journal: Neuropharmacology Date: 2006-01-09 Impact factor: 5.250
Authors: Giovanni Vacca; Salvatore Serra; Giuliana Brunetti; Mauro A M Carai; Herman H Samson; Gian Luigi Gessa; Giancarlo Colombo Journal: Alcohol Clin Exp Res Date: 2002-11 Impact factor: 3.455
Authors: Giancarlo Colombo; Salvatore Serra; Giovanni Vacca; Gian Luigi Gessa; Mauro A M Carai Journal: Eur J Pharmacol Date: 2004-05-25 Impact factor: 4.432
Authors: Mark A Smith; David L Yancey; Drake Morgan; Yu Liu; Wolfgang Froestl; David C S Roberts Journal: Psychopharmacology (Berl) Date: 2004-01-08 Impact factor: 4.530
Authors: Paola Maccioni; Daniela Vargiolu; Andrew W Thomas; Pari Malherbe; Claudia Mugnaini; Federico Corelli; Kimberly A Leite-Morris; Gian Luigi Gessa; Giancarlo Colombo Journal: Psychopharmacology (Berl) Date: 2014-11-26 Impact factor: 4.530
Authors: Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng Journal: Pharmacol Biochem Behav Date: 2012-07-25 Impact factor: 3.533
Authors: Xia Li; Victoria B Risbrough; Chelsea Cates-Gatto; Katarzyna Kaczanowska; M G Finn; Amanda J Roberts; Athina Markou Journal: Neuropharmacology Date: 2013-01-29 Impact factor: 5.250